HANDAYANI F, FITRIA N, SARI YO, A. A. IMPACT OF THE COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DOCETAXEL ON CA 15-3 BIOMARKER LEVELS IN BREAST CANCER PATIENTS: A COMPARATIVE STUDY BETWEEN DELAYED AND NON-DELAYED CHEMOTHERAPY. Int J App Pharm [Internet]. 2025 Feb. 24 [cited 2025 Dec. 5];17(1):82-8. Available from: https://www.journals.innovareacademics.in/index.php/ijap/article/view/54086